Ovid Therapeutics Inc. — All Filings
493 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
PREM14A
S-1
S-1/A
S-3
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001256153-26-000004 | Mar 25, 2026 | Mar 23, 2026 |
| S-8 | S-8 | 0001628280-26-019463 | Mar 18, 2026 | — |
| 10-K | 10-K | 0001628280-26-019438 | Mar 18, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001628280-26-019045 | Mar 18, 2026 | Mar 17, 2026 |
| 4 | — | 0002036798-26-000004 | Mar 2, 2026 | Feb 23, 2026 |
| 4 | — | 0001202098-26-000002 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | — | 0001886431-26-000002 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | — | 0001256153-26-000002 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | — | 0001368324-26-000002 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | — | 0001353128-26-000002 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | — | 0001654055-26-000002 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | — | 0001311404-26-000002 | Mar 2, 2026 | Feb 23, 2026 |
| SCHEDULE 13G | — | 0001104659-26-016662 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001315863-26-000096 | Jan 29, 2026 | — |
| 4 | — | 0002036798-26-000002 | Jan 5, 2026 | Jan 4, 2026 |
| SCHEDULE 13G | — | 0000902664-26-000036 | Jan 5, 2026 | — |
| EFFECT | — | 9999999995-25-003891 | Dec 22, 2025 | — |
| 424B3 | 424B3 | 0001193125-25-328805 | Dec 22, 2025 | — |
| SCHEDULE 13G | — | 0001346824-25-000079 | Dec 18, 2025 | — |
| 4 | — | 0001256153-25-000004 | Dec 18, 2025 | Dec 11, 2025 |
| SCHEDULE 13G | — | 0001315863-25-000859 | Dec 18, 2025 | — |
| 8-K | 8-K | 0001193125-25-323798 | Dec 18, 2025 | — |
| S-3 | S-3 | 0001193125-25-319453 | Dec 15, 2025 | — |
| 8-K | 8-K | 0001636651-25-000017 | Dec 11, 2025 | — |
| 10-Q | 10-Q | 0001636651-25-000012 | Nov 12, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001636651-25-000011 | Nov 12, 2025 | — |
| DEF 14A | DEF 14A | 0001140361-25-040884 | Nov 7, 2025 | Dec 11, 2025 |
| PRE 14A | PRE 14A | 0001140361-25-039516 | Oct 28, 2025 | Dec 11, 2025 |
| PREM14A | PREM14A | 0001140361-25-039497 | Oct 27, 2025 | Dec 11, 2025 |
| 8-K | 8-K | 0001193125-25-230409 | Oct 3, 2025 | Oct 2, 2025 |
| 8-K | 8-K | 0001193125-25-204308 | Sep 16, 2025 | Sep 11, 2025 |
| 10-Q | 10-Q | 0001628280-25-040008 | Aug 13, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001628280-25-040007 | Aug 13, 2025 | — |
| SCHEDULE 13G/A | — | 0000921895-25-002008 | Jul 21, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-003245 | Jul 17, 2025 | — |
| 8-K | 8-K | 0001628280-25-034733 | Jul 10, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-066702 | Jul 9, 2025 | — |
| 8-K | 8-K | 0001628280-25-032959 | Jun 25, 2025 | — |
| 4 | — | 0001415889-25-017698 | Jun 18, 2025 | Feb 20, 2025 |
| 4 | — | 0001415889-25-017697 | Jun 18, 2025 | Feb 20, 2025 |
| 4 | — | 0001415889-25-017696 | Jun 18, 2025 | Feb 20, 2025 |
| 4 | — | 0001415889-25-017695 | Jun 18, 2025 | Feb 20, 2025 |
| ARS | ARS | 0001628280-25-027149 | May 22, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0001628280-25-027148 | May 22, 2025 | — |
| DEF 14A | DEF 14A | 0001628280-25-027146 | May 22, 2025 | Dec 31, 2024 |
| 10-Q | 10-Q | 0001628280-25-024913 | May 13, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001628280-25-024911 | May 13, 2025 | — |
| 8-K | 8-K | 0001193125-25-111633 | May 2, 2025 | May 1, 2025 |
| PRE 14A | PRE 14A | 0001628280-25-021830 | May 2, 2025 | Apr 24, 2025 |
| 10-K/A | 10-K/A | 0001628280-25-021055 | Apr 30, 2025 | Dec 31, 2024 |